Prestige BioPharma Limited (KRX:950210)
South Korea
· Delayed Price · Currency is KRW 15,450
+1,180 (8.27%)
Last updated: Aug 14, 2025
Prestige BioPharma Market Cap
Prestige BioPharma has a market cap or net worth of 188.94 billion as of August 14, 2025. Its market cap has increased by 52.33% in one year.
Market Cap
188.94B
Enterprise Value
222.46B
Revenue
8.66B
Ranking
n/a
PE Ratio
43.45
Stock Price
15,450.00
Market Cap Chart
Since May 28, 2021, Prestige BioPharma's market cap has decreased from 360.58B to 188.94B, a decrease of -47.60%. That is a compound annual growth rate of -14.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 171.51B | -5.56% |
| Dec 30, 2024 | 181.61B | 59.39% |
| Dec 28, 2023 | 113.94B | 29.33% |
| Dec 29, 2022 | 88.10B | -64.84% |
| Dec 30, 2021 | 250.60B | -30.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.45T |
| Celltrion | 38.14T |
| ALTEOGEN | 22.98T |
| Yuhan | 8,383.50B |
| SK Biopharmaceuticals | 7,737.35B |
| PharmaResearch | 7,064.96B |
| Peptron | 6,989.21B |
| LigaChem Biosciences | 5,419.69B |